Skip to main content

Influential Chemist Dies

Carl Djerassi, who synthesized a hormone that was key to the creation of the birth control pill, has passed away at age 91.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Carl Djerassi in 2004WIKIMEDIA, CHEMICAL HERITAGE FOUNDATIONBest known for his contribution to the development of oral birth control, chemist Carl Djerassi died last week (January 30) of complications from cancer. He was 91.

After earning an undergraduate degree from Kenyon College in Ohio, Djerassi received a PhD from the University of Wisconsin-Madison in 1945. He then joined pharmaceutical company Ciba (now Novartis) before moving to drugmaker Syntex in Mexico City, where he made his pioneering discoveries on cortisone, menstrual disorders, and cancer, The New York Times (NYT) reported.

“Yes, I am proud to be called the father of the pill,” Djerassi told The Guardian in August 2000 (via NYT). “But identifying scientists is really only a surrogate for identifying the inventions or discoveries. Maybe it is true that Shakespeare’s plays would never have been written if it wasn’t for Shakespeare. But I’m certain that if we didn’t do our work, then someone else would have come along shortly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays